Analysis of direct, indirect, and intangible costs of epilepsy;Análisis de costes directos, indirectos e intangibles de la epilepsia

Neurologia

Volumn 26, Issue 1, 2011, Pages 32-38

  Pato Pato, A ^a   Cebrian Perez E ^b   Cimas Hernando, I ^a   Lorenzo Gonzalez J R ^a   Rodriguez Constenla I ^a   Gude Sampedro, F ^c  

^a HOSPITAL POVISA   (Spain)

^b HOSPITAL MONTECELO   (Spain)

^c Pediatric Nutrition Research Group Health Research Institute of Santiago de Compostela   (Spain)

Author keywords

Cost; Direct; Economics; Epilepsy; Indirect; Intangible; Pharmacoeconomics; QOLIE 10; Quality of life

Indexed keywords

ABSENTEEISM; ADOLESCENT; ARTICLE; COST BENEFIT ANALYSIS; DIAGNOSTIC TEST; EMERGENCY CARE; EPILEPSY; HOSPITAL; HOSPITAL ADMISSION; HUMAN; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL SUPPORT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COST OF ILLNESS; EPILEPSY; HOSPITALIZATION; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 79951576547     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2010.10.002     Document Type: Article

References (45)

1. Argumosa A., Herranz J.L. El coste económico de la epilepsia infantil en España. Rev Neurol. 2000, 30:104-108.
2. Meerding W.J., Bonneux L., Polder J.J., Koopmanschap M.A., Van der Maas P.J. Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study. BMJ. 1998, 317:111-115.
3. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification epilepsies and epileptic syndromes. Epilepsia. 1989;30:389-99.
4. Cramer J.A., Perrine K., Devinsky O., Meador K. A brief questionnaire to screen for quality of life in epilepsy: The QOLIE-10. Epilepsia 1996, 37:577-582.
5. Real Decreto 2388/2004, de 30 de diciembre, por el que se fija el salario mínimo interprofesional para 2005. Boletín Oficial del Estado: 31 de diciembre de 2004, Núm. 315.
6. Eucare. European white paper on epilepsy. Bruselas: Eucare; 2002.
7. INE. Instituto Nacional de Estadística. Población por edad (año a año) y sexo. Revisión del Padrón municipal 2007.
8. Manford M., Hart Y.M., Sander J.W., Shorvon S.D. The National General Practice Study of the International League Against Epilepsy applied to epilepsy in a general population. Arch Neurol. 1992, 49:801-808.
9. Zarrelli M.M., Beghi E., Rocca W.A., Huaser W.A. Incidence of epileptic syndromes in Rochester, Minnesota: 1980-1984. Epilepsia 1999, 40:1708-1714.
10. Cockerell O.C., Johnson A.L., Sander J.W., Shorvon S.D. Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia 1997, 28:31-46.
11. Herranz JL, Sellers G. Análisis de datos epidemiológicos de la epilepsia en España. Estudio GABA 2000. Madrid: CIBEST, 1996.
12. Collaborative Group for the Study of Epilepsy. Prognosis of epilepsy in new referred patients. A multicentre prospective study of the effects of monotherapy on the long-term course of epilepsy. Epilepsia. 1992;33:45-51.
13. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N Engl J Med. 2000, 342:314-319.
14. Perucca E. Antiepileptic drug monotherapy versus polytherapy: The on-going controversy. Epilepsia 1997, 38:1-20.
15. Rufo-Campos M., Sancho-Rieger J., Peña P., Masramon X., Rejas-Gutierrez J. Pautas terapéuticas en el paciente con epilepsia farmacorresistente en consultas ambulatorias de neurología y epilepsia en España. Rev Neurol. 2008, 47:517-524. Grupo de colaboradores del estudio LINCE.
16. Beghi E., Garattini L., Ricci E., Cornago D., Parazzini F. Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS). Epilepsia 2004, 45:171-178. EPICOS group.
17. Landmark C.J., Rytter E., Johannessen S.I. Clinical use of antiepileptic drugs at referral centre for epilepsy. Seizure. 2007, 16:356-364.
18. Abasolo-Osinaga E., Abecia-Inchaurregui L.C., Etxeandia-Ikobaltzeta I., Burgos-Alonso J., García del Pozo J. Estudio famarcoepidemiológico del consumo de fármacos antiepilépticos (1992-2004). Rev Neurol. 2008, 46:449-453.
19. Instituto de estudios fiscales, editores. Informe para el análisis del gasto sanitario. Madrid: Artegraf, 2006.
20. Strzelczyk A., Reese J.P., Dodel R., Hamer H.M. Cost of epilepsy. A systematic review. Pharmacoeconomics. 2008, 26:463-476.
21. Guerrini R., Battini R., Ferrari A.R., Veggiotti P., Besana D., Gobbi G., et al. The cost of childhood epilepsy in Italy: comparative findings from three health care settings. Epilepsia 2001, 42:641-646.
22. Falip M., Artazcoz L., de la Peña P., Pérez-Sempere A., Codina M. Clinical characteristic associated with psychosocial functioning among patients with uncomplicated epilepsy in Spain. Seizure. 2007, 16:195-203. Epilepsy Study Group of the Spanish Society of Neurology.
23. Hart Y.M., Shorvon S.D. The nature of epilepsy in the general population. I. Characteristic of patients receiving medication for epilepsy. Epilepsy Res. 1995, 21:43-49.
24. Jacoby A., Buck D., Baker G., McNamee P., Graham-Jones S., Chadwick D. Uptake and cost of care for epilepsy: findings from a U.K. regional study. Epilepsia 1998, 39:776-786.
25. Smeets V.M., van Lierop B.A., Vanhoutvin J.P., Aldenkamp A.P., Nijhuis F.J. Epilepsy and employment: literature review. Epilepsy Behav. 2007, 10:354-362.
26. Elwes R.D., Marshall J., Beattie A., Newman P.K. Epilepsy and employment: a community based survey in an area of high unemployment. J Neurol Neurosurg Psychiatry. 1991, 54:200-203.
27. Collings J.A., Chappell B. Correlates of employment history and employability in a British epilepsy sample. Seizure. 1994, 3:255-262.
28. Chaplin J.E., Wester A., Tomson T. Factors associated with the employment problems of people with established epilepsy. Seizure. 1998, 7:299-303.
29. Fisher R.S., Vickrey B.G., Gibson P., Hermann B., Penovich P., Scherer A., et al. The impact of epilepsy from the patient's perspective: I. Descriptions and subjective perceptions. Epilepsy Res. 2000, 41:39-51.
30. Heaney D.C. Epilepsy at work: evaluating the cost of epilepsy in the workplace. Epilepsia 1999, 40:S44-47.
31. Jacoby A. Impact of epilepsy on employment status: findings from a UK study of people with well-controlled people with epilepsy. Epilepsy Res. 1995, 21:125-132.
32. Murray M.I., Halpern M.T., Leppik I.E. Cost of refractory epilepsy in adults in the USA. Epilepsy Res. 1996, 23:139-148.
33. Andlin-Sobocki P., Jhonson B., Wittchen H.U., Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol. 2005, 12(Suppl 1):S1-27.
34. INE. Instituto Nacional de Estadística. Indicadores Sociales de España; 2005.
35. Banks GK, Regan KJ, Beran RG. The prevalence and direct costs of epilepsy in Australia. En: Beran RG, Pachlatko C, editors. Costs of epilepsy: Proceedings of the 20th International Epilepsy Congress; 1995; Wehr-Baden. Ciba-Geigy Verlag; 1995. p. 39-48.
36. Hamer H.M., Spottke A., Aletsee C., Knake S., Reis J., Strzelczyk A., et al. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy centre in Germany. Epilepsia 2006, 47:2165-2172.
37. Argumosa A., Herranz J.L. Childhood epilepsy: a critical review of cost-of-illness studies. Epileptic Disord. 2004, 6:31-40.
38. Viteri C., Codina M., Cobaleda S., Lahuerta J., Barriga J., Barrera S., et al. Validación de la versión española del cuestionario de calidad de vida en epilepsia QOLIE-10. Neurología. 2008, 23:157-167.
39. Jacoby A. Stigma, epilepsy and quality of life. Epilepsy Behav. 2002, 3:S10-20.
40. Baker G.A., Jacoby A., Buck D., Stalgis C., Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 1997, 38:353-362.
41. Jacoby A., Snape D., Baker G.A. Epilepsy and social identity: the stigma of a chronic neurological disorder. Lancet Neurol. 2005, 4:171-178.
42. Lee S.A., Yoo H.J., Lee B.I. Factors contributing to the stigma of epilepsy. Seizure. 2005, 14:157-163. Korean QoL in Epilepsy Study Group.
43. Harden C.L., Kossoy A., Vera S., Nikolov B. Reaction to epilepsy in the workplace. Epilepsia 2004, 45:1134-1140.
44. Cooper M. Epilepsy and employment-employers attitudes. Seizure. 1995, 4:193-199.
45. Wagner A.K., Bungay K.M., Kosinski M., Bromfield E.B., Ehrenberg B.L. The health status of adults with epilepsy compared with that of people without chronic conditions. Pharmacotherapy. 1996, 16:1-9.